LB Pharmaceuticals separates from Dr. Anna Eramo with severance through June 2027
LB Pharmaceuticals Inc. terminated employment of Dr. Anna Eramo effective June 15, 2026, with severance payments through September 2026 and potential extension through June 2027 pending consulting agreement compliance. The executive separation includes base salary continuation an
View filing at SEC.gov →